top of page

Scientific studies on mRNA

Multisegmental herpes zoster in a healthy 20-year-old man after COVID-19 vaccination

ID

Oral Herpes Zoster Infection Following COVID-19 Vaccination, A Report of Five Cases

ID

Plantar herpes zoster following heterologous recombinant adenovirus-based COVID-19 vaccine

ID

Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2

ID

Reactivation of varicella-zoster virus following mRNA COVID-19 vaccination in a patient with moderately differentiated adenocarcinoma of rectum, A case report

ID

Recurrence of Herpetic Keratitis after COVID-19 Vaccination, A Report of Two Cases

ID

Response to Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination, Report of 5 cases

ID

Secondary Syphilis Unmasked by BNT162b2 mRNA COVID-19 Vaccine

ID

Streptococcus gordonii septic arthritis of the glenohumeral joint following deltoid intramuscular vaccination

ID

The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus

ID

Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine

MIS-V

Multisystem Inflammatory Syndrome in Adults or Hemophagocytic Lymphohistiocytosis, A Clinical Conundrum in Fully Vaccinated Adults With Breakthrough COVID-19 Infections

MIS-V

Multisystem Inflammatory Syndrome in an Adult Following COVID-19 mRNA Vaccination, Successful Treatment With Medium-Dose Steroids and Colchicine

MIS-V

Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)

MIS-V

Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination

MIS-V

Multisystem inflammatory syndrome in children (MIS-C) secondary to COVID-19 mRNA vaccination - A case report from Qatar

MIS-V

Multisystem inflammatory syndrome in Children After BNT162b2 Messenger RNA SARS-CoV-2 Vaccination

MIS-V

Multisystem Inflammatory Syndrome in Children After Breakthrough Infection in a COVID-19-vaccinated Child

MIS-V

Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France

MIS-V

Multisystem inflammatory syndrome with erythema multiforme-like rash in an adult after mRNA COVID-19 vaccination

MIS-V
bottom of page